Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
Abstract Background Patients using opioids to treat chronic non-cancer pain often experience side effects that may affect health-related quality of life (HRQOL). These side effects include opioid-induced constipation (OIC), sedation, dizziness, and nausea. OIC can significantly affect HRQOL for pati...
Main Authors: | Michelle S. Keller, Alma Jusufagic, Brennan M. R. Spiegel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12876-019-1097-7 |
Similar Items
-
Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey
by: Coluzzi F, et al.
Published: (2021-07-01) -
Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients
by: Regina Gironés Sarrió, et al.
Published: (2021-01-01) -
Management of Constipation in Hospitalized Patients
by: Gregory S. Sayuk, et al.
Published: (2023-09-01) -
Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
by: Webster LR, et al.
Published: (2018-10-01) -
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies
by: Chamberlain BH, et al.
Published: (2021-09-01)